McKenzie R, Riley T J, Tantisira B, Hamilton D L
Department of Anesthesiology, Magee-Womens Hospital, Pittsburgh, PA 15213, USA.
J Clin Anesth. 1997 Feb;9(1):15-20. doi: 10.1016/S0952-8180(96)00215-2.
To test the hypothesis that for major gynecologic surgery the combination of propofol for induction, ondansetron, and dexamethasone would be a more effective antiemetic combination than propofol for induction, ondansetron, and saline; and to determine if a propofol induction of anesthesia improved our previously reported results when thiamylal was the induction drug.
Double-blind, randomized study.
Magee-Womens Hospital, Pittsburgh, Pennsylvania.
80 healthy ASA physical status I, II, and III female inpatients scheduled for major gynecologic surgery.
After induction of anesthesia with propofol, Group 1 received intravenous (IV) ondansetron 4 mg and saline, and Group 2 received IV ondansetron 4 mg followed by IV dexamethasone 20 mg.
For Group 1 and Group 2, respectively, no emesis and no rescue occurred in 15 (37.5%) and 21 (52.5%) patients (p = 0.13); emesis occurred in 7 (17.5%) Group 1 patients and 5 (12.5%) Group 2 patients, rescue antiemetic 23 (57.5%) Group 1 patients and 19 (47.5%) Group 2 patients. Nausea was reported by 31 (77.5%) Group 1 patients and 30 (75%) Group 2 patients.
The hypothesis that the addition of dexamethasone to the propofolondansetron combination would significantly reduce postoperative nausea and vomiting (PONV) was not confirmed. A propofol induction of anesthesia resulted in a comparable incidence of PONV when compared with our previously reported results using thiamylal for induction of anesthesia for women having major gynecologic operations.
检验以下假设,即对于大型妇科手术,丙泊酚诱导联合昂丹司琼和地塞米松的联合用药方案比丙泊酚诱导联合昂丹司琼和生理盐水的方案更有效地预防恶心呕吐;并确定当硫喷妥钠作为诱导药物时,丙泊酚诱导麻醉是否能改善我们之前报告的结果。
双盲、随机研究。
宾夕法尼亚州匹兹堡市的梅杰妇女医院。
80例计划进行大型妇科手术的ASA身体状况为I、II和III级的健康女性住院患者。
用丙泊酚诱导麻醉后,第1组静脉注射(IV)4 mg昂丹司琼和生理盐水,第2组静脉注射4 mg昂丹司琼,随后静脉注射20 mg地塞米松。
第1组和第2组分别有15例(37.5%)和21例(52.5%)患者未出现呕吐且无需补救用药(p = 0.13);第1组有7例(17.5%)患者出现呕吐,第2组有5例(12.5%)患者出现呕吐,第1组有23例(57.5%)患者需要补救性使用抗呕吐药物,第2组有19例(47.5%)患者需要。第1组有31例(77.5%)患者报告有恶心,第2组有30例(75%)患者报告有恶心。
丙泊酚 - 昂丹司琼联合用药方案中加入地塞米松可显著降低术后恶心呕吐(PONV)的假设未得到证实。与我们之前报告的使用硫喷妥钠诱导麻醉进行大型妇科手术的女性患者相比,丙泊酚诱导麻醉导致的PONV发生率相当。